Bone Biologics Corporation (BBLGW) Shareholders’ equity 2016–2020
Bone Biologics Corporation (BBLGW) shareholders’ equity at each fiscal year-end, per SEC filings.
-$13.7MFY2020 · since FY2016: -$8.4M → -$13.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -$13.7M | -15.4% |
| FY2019 | -$11.9M | — |
| FY2016 | -$8.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BBLGW financial trends
BBLGW RevenueBBLGW Net incomeBBLGW Net marginBBLGW Gross profitBBLGW Gross marginBBLGW Operating incomeBBLGW Operating marginBBLGW Operating cash flowBBLGW Free cash flowBBLGW Capital expendituresBBLGW Return on equityBBLGW Stock buybacksBBLGW Dividends paidBBLGW Total assetsBBLGW Total liabilitiesBBLGW overview →